Guidance for Industry: Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices
Creator
Unknown authorBibliographic Citation
United States. Department of Health and Human Services. Food and Drug Administration [FDA]. Office of the Commissioner, Office of Policy January, 2009. 8p. [Online]. Accessed: http://www.fda.gov/RegulatoryInformation/Guidances/ucm125126.htm [2009 October 2]
Permanent Link
Find in a Libraryhttp://timetravel.mementoweb.org/memento/2009/http://www.fda.gov/RegulatoryInformation/Guidances/ucm125126.htm
http://hdl.handle.net/10822/952300
Date
2009-01Subject
Publisher
United States. Department of Health and Human Services. Food and Drug Administration [FDA]. Office of the Commissioner, Office of Policy
Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Off-Label or Out of Bounds? Prescriber and Marketer Liability for Unapproved Uses of FDA-Approved Drugs
O'Reilly, James; Dalal, Amy (2003-06)